{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:04:57Z","timestamp":1771232697672,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Constipation is a significant symptom of Parkinson's disease (PD). Glial-derived neurotrophic factor (GDNF) is important for the morphogenesis of the enteric nervous system and plays a critical role in the preservation of mucosal integrity under enteric glia surveillance. The aim of this work was to evaluate the serum levels of GDNF in patients with PD with and without constipation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This work included 128 patients with PD. The patients were classified into three groups: those with PD but no constipation (nCons-PD) (<jats:italic>n<\/jats:italic> = 49), those with prodromal stage constipation (Cons-Pro-PD) (<jats:italic>n<\/jats:italic> = 48), and those with clinical stage constipation (Cons-Clinic-PD) (<jats:italic>n<\/jats:italic> = 31). The association between serum GDNF concentration and constipation was explored using logical regression.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The nCons-PD group's mean GDNF levels were 528.44 pg\/ml, which was higher than the Cons-Pro-PD group's 360.72 pg\/ml and the Cons-Clinic-PD group's 331.36 pg\/ml. The results of binary logistic regression indicated that GDNF was a protective factor in the prevention of constipation. Cons-Clinic-PD group had a higher score of MDS-UPDRS-II, MDS-UPDRS-III, MDS-UPDRS-IV, and a higher H-Y staging as compared with nCons-PD group. Relative to the nCons-PD group, Cons-Clinic-PD had higher NMSS scores, lower MoCA and PDSS scores, and were more likely to have RBD.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> GDNF serum levels are lower in patients with PD who are constipated. A low GDNF level is a potential risk factor for constipation in patients with PD.<\/jats:p>","DOI":"10.3389\/fneur.2021.777591","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:34:16Z","timestamp":1642048456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Lower GDNF Serum Level Is a Possible Risk Factor for Constipation in Patients With Parkinson Disease: A Case\u2013Control Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Gang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinzhen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piniel Alphayo","family":"Kambey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zai-li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zai-e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiao-ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao","family":"Dian-shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1212\/01.wnl.0000278071.91524.4d","article-title":"How common are the \u201ccommon\u201d neurologic disorders?","volume":"6","author":"Kaplin","year":"2007","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736","article-title":"Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES recommendations for the diagnosis of Parkinson's disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Euro J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1002\/mds.22719","article-title":"Parkinson's at risk syndrome: can Parkinson's disease be predicted?","volume":"25","author":"Stern","year":"2010","journal-title":"Mov Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s1474-4422","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JPD-2011-001","article-title":"Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database","volume":"1","author":"Makaroff","year":"2011","journal-title":"J Parkinsons Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson Disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding Parkinson's disease: a systematic review and meta-analysis","volume":"87","author":"Adams-Carr","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JPD-161050","article-title":"Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson's Disease: a colon transit and volume study","volume":"7","author":"Knudsen","year":"2017","journal-title":"J Parkinsons Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.gastro.2017.07.002","article-title":"Enteric glia regulate gastrointestinal motility but are not required for maintenance of the epithelium in mice","volume":"153","author":"Rao","year":"2017","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mcn.2015.03.018","article-title":"Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells","volume":"68","author":"Brun","year":"2015","journal-title":"Mol Cell Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/JAD-150172","article-title":"Decreased neurotrophic support is associated with cognitive decline in non-demented subjects","volume":"46","author":"Forlenza","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4103\/1673-5374.297091","article-title":"Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson's disease: a case-control study","volume":"16","author":"Shi","year":"2021","journal-title":"Neural Regen Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in parkinson's disease: subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/jci.insight.92295","article-title":"\u03b1-Synuclein in gut endocrine cells and its implications for Parkinson's disease","volume":"2","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"key":"B21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's Disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron."},{"key":"B22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12035-014-8730-9","article-title":"GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation","volume":"50","author":"Xiao","year":"2014","journal-title":"Mol Neurobiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1172\/JCI120261","article-title":"Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease","volume":"129","author":"Meir","year":"2019","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12888-019-2231-3","article-title":"Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pnpbp.2017.03.013","article-title":"Cognitive impairment in first-episode drug-naive patients with schizophrenia: relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor","volume":"76","author":"Xiao","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2018.02.034","article-title":"Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia","volume":"263","author":"Man","year":"2018","journal-title":"Psychiatry Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neulet.2014.05.034","article-title":"Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia","volume":"575","author":"Niitsu","year":"2014","journal-title":"Neurosci Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1727","DOI":"10.1002\/mpr.1727","article-title":"Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia","volume":"27","author":"Ye","year":"2018","journal-title":"Int J Methods Psychiatr Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.parkreldis.2019.08.010","article-title":"The gut microbiota: a novel therapeutic target in Parkinson's disease?","volume":"66","author":"Lubomski","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41575-019-0222-y","article-title":"Management of functional constipation in children and adults","volume":"17","author":"Vriesman","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/mds.28312","article-title":"Differences in the presentation and progression of Parkinson's Disease by sex","volume":"36","author":"Iwaki","year":"2021","journal-title":"Mov Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11910-016-0655-4","article-title":"Imaging systemic dysfunction in Parkinson's Disease","volume":"16","author":"Borghammer","year":"2016","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.clineuro.2012.07.032","article-title":"Prevalence of non motor features in a cohort of Parkinson's disease patients","volume":"115","author":"Khedr","year":"2013","journal-title":"Clin Neurol Neurosurg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of non-motor symptoms in Parkinson's disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/mds.23826","article-title":"Do nonmotor symptoms in Parkinson's disease differ from normal aging?","volume":"26","author":"Krishnan","year":"2011","journal-title":"Mov Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26004","article-title":"Visual hallucinations in Parkinson's disease: theoretical models","volume":"29","author":"Muller","year":"2014","journal-title":"Mov Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"567574","DOI":"10.3389\/fneur.2020.567574","article-title":"Depression is associated with constipation in patients with Parkinson's Disease","volume":"11","author":"Xiao-Ling","year":"2020","journal-title":"Front Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00415-014-7609-z","article-title":"Erratum to: autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study","volume":"262","author":"Ferini-Strambi","year":"2015","journal-title":"J Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.777591\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:34:18Z","timestamp":1642048458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.777591\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":40,"alternative-id":["10.3389\/fneur.2021.777591"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.777591","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"777591"}}